Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

         

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Aeterna Laboratories Inc. BioPharma

Æterna Laboratories Inc. is a biopharmaceutical company focused on the development of new therapeutics for unmet medical needs, principally cancer. Æterna's Biopharmaceutical Division focuses on the development of Æ-941, an angiogenesis-inhibiting compound extracted from shark cartilage. The clinical development program of Æ-941 is directed at first line and combination therapy for cancer, psoriasis and age-related macular degeneration. In early 1998, Æ-941 became the first angiogenic inhibitor under clinical study in three therapeutic fields: oncology, dermatology and ophthalmology.


Activity:

- Manufacturing
- Research & Development


Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics


Therapeutic targets:

- Aging
- Cancer
- Dermatology
- Hematology
- Oncology
- Ophthalmology

Company Contact

Aeterna Laboratories Inc.
1405 Parc-technologique Blvd
G1P4P5 Québec
Québec
Canada
Phone: (418)652 8525
FAX:
Website: www.aeterna.com

Markets Covered

a. HeadQuarter: Canada

b. Continent(s) active: North America

c. Countries active:


Corporate data:

Number of Employees: 270

Turnover:
Amount: Year: Currency:

Year founded:

Stock options:
SymbolExchange
1AELToronto Stock Exchange
SymbolExchange
2AELANasdaq


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: 02-Apr-2003.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search